SMYD2 and chronic kidney disease: Western blot analysis revealed that the expression levels of SMYD2 and its specific methylation substrate, H3K4me3, were significantly elevated in the kidney tissues of cisplatin‐induced CKD mice, while AZ505 effectively inhibited the upregulation of both SMYD2 and H3K4me3 (Figure 1C,D).